Arno Therapeutics, Inc Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2016-09-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2016-09-30..
- Interest coverage · 12 months: Value -261.86×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2016-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2016-09-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2016-09-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | -261.86× | Operating income ÷ reported interest expense. $-11.06M ÷ $42.25K ≈ -261.86× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 6.45M USD | Research and Development Expense |
| Revenue | (m) | |
| Stock-based compensation | 3.56M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -11.06M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 42.25K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $6.45M | (m) | $3.56M | $-11.06M | $42.25K | (m) | (m) | -261.86× | Reported |
| 2016-06-30 | $7.13M | (m) | $3.47M | $-11.71M | $42.38K | (m) | (m) | -276.21× | Reported |
| 2016-03-31 | $7.72M | (m) | $3.42M | $-12.37M | $42.51K | (m) | (m) | -291.09× | Reported |
| 2015-12-31 | $8.65M | (m) | $3.47M | $-13.41M | $28.40K | (m) | (m) | -472.20× | Reported |
| 2015-09-30 | $9.48M | (m) | $3.88M | $-14.61M | $1.28K | (m) | (m) | -11393.78× | Reported |
| 2015-06-30 | $11.44M | (m) | $4.03M | $-17.41M | $933.00 | (m) | (m) | -18657.60× | Reported |
| 2015-03-31 | $12.88M | (m) | $4.32M | $-19.19M | $553.00 | (m) | (m) | -34705.32× | Reported |
| 2014-12-31 | $14.84M | (m) | $4.52M | $-21.49M | $143.00 | (m) | (m) | -150302.98× | Reported |
| 2014-09-30 | $16.85M | (m) | $4.03M | $-23.50M | $12.69M | (m) | (m) | -1.85× | Reported |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $4.14M | (m) | $249.29K | $-5.03M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.